Compagnie des Alpes S.A. (CDA)
Euronext Paris · France · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 17.46 |
|---|---|
| 52-week range | 16.20 – 27.70 |
| Return, 1 month / 3 months | −3.7% / −16.7% |
| Return, 1 year / 3 years | −15.0% / +57.1% |
| Trend | Below its 200-day average |
| RSI (14) | 48 |
| Volatility (1 year) | 28.4% |
| Worst drawdown (1 year) | -40.6% |
| Average daily value traded | 0.81M EUR |
| Dividend yield | 6.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Compagnie des Alpes is a French leisure company based in Paris. It operates mountain ski areas in the French Alps, running lifts, slopes and related resort services for winter sports visitors. The company also owns and manages theme parks and family attractions, including Parc Astérix near Paris and a group of wax museums, drawing day visitors and tourists. Its activities combine seasonal mountain recreation with amusement and cultural attractions in France and elsewhere in Europe.
The shares are listed on the Euronext Paris in France under the code CDA, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Compagnie des Alpes S.A. (CDA) trades on the Euronext Paris in France. It last closed at EUR 17.46 on 19 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 389 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 15.0% and over the last three months it fell 16.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 26 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -21.6% | ||
| From 52-week high | -37.0% | ||
| Momentum | 31 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -16.7% | ||
| 6-month return | -30.0% | ||
| 12-month return, skipping the last month | -11.7% | ||
| Risk (lower is better) | 57 · Fair | Typical risk for this exchange. | |
| Volatility (1 year) | 28.4% | ||
| Worst drawdown (1 year) | -40.6% | ||
| Liquidity | 78 · Strong | Trades actively. | |
| Average daily value traded | 0.81M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 48 · Weak | Dividend is small or irregular. | |
| Dividend yield | 6.3% | ||
| Years with dividends | 4 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +5.7% |
|---|---|
| 1 month | −3.7% |
| 3 months | −16.7% |
| 6 months | −30.0% |
| 1 year | −15.0% |
| 3 years | +57.1% |
| 5 years | +56.5% |
Signals
| 50-day / 200-day average | 18.67 / 22.28 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.40 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 23 Mar 2026 | EUR 1.1000 |
| 21 Mar 2025 | EUR 1.0000 |
| 20 Mar 2024 | EUR 0.9100 |
| 14 Mar 2023 | EUR 0.8300 |
| 10 Mar 2020 | EUR 0.7000 |
| 12 Mar 2019 | EUR 0.6500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.